http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010122324-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0078 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-10 |
| filingDate | 2008-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2010122324-A |
| titleOfInvention | POLYSACCHARIDE COMPOSITIONS NOT POSSESSING ANTICOAGULANT PROPERTIES |
| abstract | 1. A polysaccharide preparation having the following characteristics:! (a) mass-average molecular weight of the chain 3500-7000 Yes; ! (b) anti-Xa activity and anti-IIa activity of less than 50 IU / mg for each activity; and! (c) more than 5% and less than 50% of glycol cleaved uronic acid residues. ! 2. The drug according to claim 1, containing less than 30% of glycol cleaved uronic acid residues. ! 3. The drug according to claim 1, where the preparation contains 10-30% of glycol cleaved uronic acid residues. ! 4. A polysaccharide preparation having the following characteristics:! (a) a weight average molecular weight of a chain of 3,500-7,000 Da; ! (b) anti-Xa activity and anti-IIa activity of less than 50 IU / mg for each activity; ! (c) a polysaccharide chain containing the residue of a glycol cleaved uronic acid (UG); and! (d) polysaccharide chains, each of which contains no more than 3 residues of glycol-cleaved uronic acid (UG). ! 5. The drug according to claim 4, where each polysaccharide chain contains not more than 2 residues of glycol-cleaved uronic acid (UG). ! 6. A polysaccharide preparation having the following characteristics:! (a) a weight average molecular weight of a chain of 3,500-7,000 Da; ! (b) anti-Xa activity and anti-IIa activity of less than 50 IU / mg for each activity; and! (c) polysaccharide chains containing on average 0.2-3 residues of glycol-cleaved uronic acid (UG) per polysaccharide chain. ! 7. The drug according to claim 6, containing on average no more than 1 residue of glycol-cleaved uronic acid (UG) per polysaccharide chain. ! 8. A composition comprising a polysaccharide preparation having the following characteristics:! (a) a weight average molecular weight of a chain of 3,500-7,000 Da; ! (b) anti-Xa activity and anti-IIa activity of less than 50 IU / mg for each activity; and |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2617764-C2 |
| priorityDate | 2007-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.